Rudi Van Den Eynde has been our Head of Thematic Global Equity since 2011.
His career started in 1987 in the euro bonds department of Dexia Bank Belgium. He spent 11 years with the company in a variety of roles including 4 years as a Currency Trader and later as an Institutional Portfolio Manager.
In 1998 he joined Candriam as a Senior Equity Fund Manager, and became Head of Thematic Global Equity in 2012.
Rudi holds a bachelor’s degree of Medicine from the University of Antwerp, Belgium.
Discover the latest articles by Rudi Van Den Eynde
Outlook 2024, Rudi Van Den Eynde, Antoine Hamoir
Healthcare sector, though not in as good shape as the pandemic's end, exhibits resilience with promising indicators, when the economy may start coughing.
Malgorzata Kluba, Rudi Van Den Eynde, Oncology, Equities
World Cancer Day 2023
And we would rather not have to go through this – which would mean we won the battle and cancer is curable.
Outlook 2023, Rudi Van Den Eynde
Building a New World: Thematic Investments
In the United States Antonín Dvořák composed the New World Symphony in 1893 and Neil Armstrong took it on a cassette to the moon. Rudi Van den Eynde takes it global, presenting us a New World of long-term trends.
Q&A, Health Care, Rudi Van Den Eynde
Biotech investing: is there a doctor in the house?
Rudi Van Den Eynde, Head of Thematic Global Equity at
Candriam, answers investors’ questions about a sector where
depth of specialist knowledge is a prerequisite to consistent
stock selection success.
Oncology, Q&A, Rudi Van Den Eynde, Equities
Investing in oncology: forewarned is forearmed
Rudi Van Den Eynde, Head of Thematic Global Equity at Candriam, explains to investors the approach he used to create and develop an investment strategy in the oncology sector.